Odds Ratios of Adherence and Continuation of Adjuvant Endocrine Therapy Over Time Associated With Demographic Factors in Medicaid-Insured Women With Hormone Receptor–Positive Breast Cancer Diagnosed Before 65 Years of Age. This evidence concerns the gene NR4A1 and breast carcinoma.